These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30475198)

  • 1. Where are we at with model-based economic evaluations of interventions for dementia? a systematic review and quality assessment.
    Nguyen KH; Comans TA; Green C
    Int Psychogeriatr; 2018 Nov; 30(11):1593-1605. PubMed ID: 30475198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-based economic evaluation in Alzheimer's disease: a review of the methods available to model Alzheimer's disease progression.
    Green C; Shearer J; Ritchie CW; Zajicek JP
    Value Health; 2011; 14(5):621-30. PubMed ID: 21839398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
    Hernandez L; Ozen A; DosSantos R; Getsios D
    Pharmacoeconomics; 2016 Jul; 34(7):681-707. PubMed ID: 26899832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment.
    Darab MG; Engel L; Henzler D; Lauerer M; Nagel E; Brown V; Mihalopoulos C
    Appl Health Econ Health Policy; 2024 Jul; 22(4):503-525. PubMed ID: 38554246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling disease progression in Alzheimer's disease: a review of modelling methods used for cost-effectiveness analysis.
    Green C
    Pharmacoeconomics; 2007; 25(9):735-50. PubMed ID: 17803333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic literature review of methodologies and data sources of existing economic models across the full spectrum of Alzheimer's disease and dementia from apparently healthy through disease progression to end of life care: a systematic review protocol.
    Karagiannidou M; Wittenberg R; Landeiro FIT; Park AL; Fry A; Knapp M; Gray AM; Tockhorn-Heidenreich A; Castro Sanchez AY; Ghinai I; Handels R; Lecomte P; Wolstenholme J;
    BMJ Open; 2018 Jun; 8(6):e020638. PubMed ID: 29884696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing Alzheimer's disease: a systematic review of economic evaluations.
    Handels RL; Wolfs CA; Aalten P; Joore MA; Verhey FR; Severens JL
    Alzheimers Dement; 2014 Mar; 10(2):225-37. PubMed ID: 23727080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How relevant are social costs in economic evaluations? The case of Alzheimer's disease.
    Peña-Longobardo LM; Rodríguez-Sánchez B; Oliva-Moreno J; Aranda-Reneo I; López-Bastida J
    Eur J Health Econ; 2019 Nov; 20(8):1207-1236. PubMed ID: 31342208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health economic evaluations of non-pharmacological interventions for persons with dementia and their informal caregivers: a systematic review.
    Nickel F; Barth J; Kolominsky-Rabas PL
    BMC Geriatr; 2018 Mar; 18(1):69. PubMed ID: 29523090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of decision analytic modeling in the health economic assessment of spinal intervention.
    Edwards NC; Skelly AC; Ziewacz JE; Cahill K; McGirt MJ
    Spine (Phila Pa 1976); 2014 Oct; 39(22 Suppl 1):S16-42. PubMed ID: 25299257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.
    Mavranezouli I; Lokkerbol J
    Pharmacoeconomics; 2017 Mar; 35(3):271-296. PubMed ID: 28000158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic Evaluations of Multicomponent Disease Management Programs with Markov Models: A Systematic Review.
    Kirsch F
    Value Health; 2016 Dec; 19(8):1039-1054. PubMed ID: 27987631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the Economic Impact of Interventions for Older Populations with Multimorbidity: A Method of Linking Multiple Single-Disease Models.
    Youn JH; Stevenson MD; Thokala P; Payne K; Goddard M
    Med Decis Making; 2019 Oct; 39(7):842-856. PubMed ID: 31431188
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic review of decision analytic modeling techniques for the economic evaluation of dental caries interventions.
    Qu Z; Zhang S; Krauth C; Liu X
    PLoS One; 2019; 14(5):e0216921. PubMed ID: 31091279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Utility Analyses of Interventions for Informal Carers: A Systematic and Critical Review.
    Guets W; Al-Janabi H; Perrier L
    Pharmacoeconomics; 2020 Apr; 38(4):341-356. PubMed ID: 31853801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility-Based Instruments for People with Dementia: A Systematic Review and Meta-Regression Analysis.
    Li L; Nguyen KH; Comans T; Scuffham P
    Value Health; 2018 Apr; 21(4):471-481. PubMed ID: 29680105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dependence Levels as Interim Clinical Milestones Along the Continuum of Alzheimer's Disease: 18-Month Results from the GERAS Observational Study.
    Kahle-Wrobleski K; Andrews JS; Belger M; Ye W; Gauthier S; Rentz DM; Galasko D
    J Prev Alzheimers Dis; 2017; 4(2):72-80. PubMed ID: 29186278
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.